Gut microbiota and non-alcoholic fatty liver disease

Hepatobiliary and Pancreatic Diseases International

Volumn 14, Issue 6, 2015, Pages 572-581

  Gkolfakis, Paraskevas ^a   Dimitriadis, George ^a   Triantafyllou, Konstantinos ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

16S rRNA sequencing; archaea; gut microbiota; non alcoholic fatty liver disease; non alcoholic steatohepatitis

Indexed keywords

ALCOHOL; CHOLINE; PROBIOTIC AGENT;

ARCHAEON; BACTERIAL OVERGROWTH; BACTEROIDETES; BREATH ANALYSIS; DISEASE COURSE; DYSBIOSIS; FIRMICUTES; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIPOPOLYSACCHARIDE-INDUCED ENDOTOXEMIA; MEDLINE; METABOLIC SYNDROME X; METHANOGENIC ARCHAEON; MICROBIOME; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; REVIEW; BACTERIAL LOAD; BACTERIAL TRANSLOCATION; BACTERIUM; CLASSIFICATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; INTESTINE; MICROBIOLOGY; NON-ALCOHOLIC FATTY LIVER DISEASE; PROGNOSIS; RIBOTYPING; RISK FACTOR;

BACTERIA; BACTERIAL LOAD; BACTERIAL TRANSLOCATION; BREATH TESTS; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINES; NON-ALCOHOLIC FATTY LIVER DISEASE; PROBIOTICS; PROGNOSIS; RIBOTYPING; RISK FACTORS;

EID: 84951842463     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(15)60026-1     Document Type: Review

References (97)

1. E Bugianesi, AJ McCullough, G Marchesini Insulin resistance: a metabolic pathway to chronic liver disease Hepatology 42 2005 987 1000
2. N Bhala, RI Jouness, E Bugianesi Epidemiology and natural history of patients with NAFLD Curr Pharm Des 19 2013 5169 5176
3. N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology 55 2012 2005 2023
4. A Duseja, YK Chawla Obesity and NAFLD: the role of bacteria and microbiota Clin Liver Dis 18 2014 59 71
5. G Targher, L Bertolini, S Rodella, R Tessari, L Zenari, G Lippi et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients Diabetes Care 30 2007 2119 2121
6. P Angulo Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 51 2010 373 375
7. G Bedogni, L Miglioli, F Masutti, C Tiribelli, G Marchesini, S Bellentani Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study Hepatology 42 2005 44 52
8. CL Ogden, MD Carroll, LR Curtin, MA McDowell, CJ Tabak, KM Flegal Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 2006 1549 1555
9. JM Clark, FL Brancati, AM Diehl The prevalence and etiology of elevated aminotransferase levels in the United States Am J Gastroenterol 98 2003 960 967
10. G Vernon, A Baranova, ZM Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 2011 274 285
11. JD Browning, LS Szczepaniak, R Dobbins, P Nuremberg, JD Horton, JC Cohen et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
12. GE Fischer, SP Bialek, CE Homan, SE Livingston, BJ McMahon Chronic liver disease among Alaska-Native people, 2003-2004 Am J Gastroenterol 104 2009 363 370
13. SR Bialek, JT Redd, A Lynch, T Vogt, S Lewis, C Wilson et al. Chronic liver disease among two American Indian patient populations in the southwestern United States, 2000-2003 J Clin Gastroenterol 42 2008 949 954
14. CP Day, OF James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
15. JK Dowman, JW Tomlinson, PN Newsome Pathogenesis of non-alcoholic fatty liver disease QJM 103 2010 71 83
16. H Tilg, AR Moschen Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis Hepatology 52 2010 1836 1846
17. EK Speliotes, JL Butler, CD Palmer, BF Voight, GIANT Consortium, MIGen Consortium et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease Hepatology 52 2010 904 912
18. AS Neish Microbes in gastrointestinal health and disease Gastroenterology 136 2009 65 80
19. JK Nicholson, E Holmes, ID Wilson Gut microorganisms, mammalian metabolism and personalized health care Nat Rev Microbiol 3 2005 431 438
20. I Sekirov, SL Russell, LC Antunes, BB Finlay Gut microbiota in health and disease Physiol Rev 90 2010 859 904
21. SR Gill, M Pop, RT Deboy, PB Eckburg, PJ Turnbaugh, BS Samuel et al. Metagenomic analysis of the human distal gut microbiome Science 312 2006 1355 1359
22. PB Eckburg, EM Bik, CN Bernstein, E Purdom, L Dethlefsen, M Sargent et al. Diversity of the human intestinal microbial flora Science 308 2005 1635 1638
23. K Triantafyllou, M Pimentel Small intestinal bacterial overgrowth BE CM Lacy JK DiBaise Functional and motility disorders of the gastrointestinal tract. A case study approach 2015 Springer+Bussiness Media New York 125 136
24. M Arumugam, J Raes, E Pelletier, D Le Paslier, T Yamada, DR Mende et al. Enterotypes of the human gut microbiome Nature 473 2011 174 180
25. L Zhu, SS Baker, C Gill, W Liu, R Alkhouri, RD Baker et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH Hepatology 57 2013 601 609
26. A Goel, M Gupta, R Aggarwal Gut microbiota and liver disease J Gastroenterol Hepatol 29 2014 1139 1148
27. PJ Turnbaugh, M Hamady, T Yatsunenko, BL Cantarel, A Duncan, RE Ley et al. A core gut microbiome in obese and lean twins Nature 457 2009 480 484
28. M Raman, I Ahmed, PM Gillevet, CS Probert, NM Ratcliffe, S Smith et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 11 2013 868 875 e1-3.
29. M Mouzaki, EM Comelli, BM Arendt, J Bonengel, SK Fung, SE Fischer et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease Hepatology 58 2013 120 127
30. VW Wong, CH Tse, TT Lam, GL Wong, AM Chim, WC Chu et al. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis-a longitudinal study PLoS One 8 2013 e62885
31. MD Spencer, TJ Hamp, RW Reid, LM Fischer, SH Zeisel, AA Fodor Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency Gastroenterology 140 2011 976 986
32. A Abu-Shanab, EM Quigley The role of the gut microbiota in nonalcoholic fatty liver disease Nat Rev Gastroenterol Hepatol 7 2010 691 701
33. F Bäckhed, H Ding, T Wang, LV Hooper, GY Koh, A Nagy et al. The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci U S A 101 2004 15718 15723
34. F Bäckhed, JK Manchester, CF Semenkovich, JI Gordon Mechanisms underlying the resistance to diet-induced obesity in germ-free mice Proc Natl Acad Sci U S A 104 2007 979 984
35. PJ Turnbaugh, RE Ley, M Hamady, CM Fraser-Liggett, R Knight, JI Gordon The human microbiome project Nature 449 2007 804 810
36. A Schwiertz, D Taras, K Schäfer, S Beijer, NA Bos, C Donus et al. Microbiota and SCFA in lean and overweight healthy subjects Obesity (Silver Spring) 18 2010 190 195
37. RE Ley, F Bäckhed, P Turnbaugh, CA Lozupone, RD Knight, JI Gordon Obesity alters gut microbial ecology Proc Natl Acad Sci U S A 102 2005 11070 11075
38. M Kalliomäki, MC Collado, S Salminen, E Isolauri Early differences in fecal microbiota composition in children may predict overweight Am J Clin Nutr 87 2008 534 538
39. RE Ley, PJ Turnbaugh, S Klein, JI Gordon Microbial ecology: human gut microbes associated with obesity Nature 444 2006 1022 1023
40. H Zhang, JK DiBaise, A Zuccolo, D Kudrna, M Braidotti, Y Yu et al. Human gut microbiota in obesity and after gastric bypass Proc Natl Acad Sci U S A 106 2009 2365 2370
41. GD Wu, J Chen, C Hoffmann, K Bittinger, YY Chen, SA Keilbaugh et al. Linking long-term dietary patterns with gut microbial enterotypes Science 334 2011 105 108
42. M Derrien, EE Vaughan, CM Plugge, WM de Vos Akkermansia muciniphila gen A human intestinal mucindegrading bacterium. Int J Syst Evol Microbiol 54 2004 1469 1476
43. A Santacruz, MC Collado, L García-Valdés, MT Segura, JA Martín-Lagos, T Anjos et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women Br J Nutr 104 2010 83 92
44. CL Karlsson, J Onnerfält, J Xu, G Molin, S Ahrné, K Thorngren-Jerneck The microbiota of the gut in preschool children with normal and excessive body weight Obesity (Silver Spring) 20 2012 2257 2261
45. AP Liou, M Paziuk, JM Luevano Jr, S Machineni, PJ Turnbaugh, LM Kaplan Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity Sci Transl Med 5 2013 178ra41
46. NR Shin, JC Lee, HY Lee, MS Kim, TW Whon, MS Lee et al. An increase in the Akkermansia spp Population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63 2014 727 735
47. A Everard, C Belzer, L Geurts, JP Ouwerkerk, C Druart, LB Bindels et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity Proc Natl Acad Sci U S A 110 2013 9066 9071
48. B Schnabl, DA Brenner Interactions between the intestinal microbiome and liver diseases Gastroenterology 146 2014 1513 1524
49. T Sarkola, CJ Eriksson Effect of 4-methylpyrazole on endogenous plasma ethanol and methanol levels in humans Alcohol Clin Exp Res 25 2001 513 516
50. P Hartmann, WC Chen, B Schnabl The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease Front Physiol 3 2012 402
51. S Nair, K Cope, TH Risby, AM Diehl Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis Am J Gastroenterol 96 2001 1200 1204
52. SS Baker, RD Baker, W Liu, NJ Nowak, L Zhu Role of alcohol metabolism in non-alcoholic steatohepatitis PLoS One 5 2010 e9570
53. V Volynets, MA Küper, S Strahl, IB Maier, A Spruss, S Wagnerberger et al. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD) Dig Dis Sci 57 2012 1932 1941
54. R Rao Endotoxemia and gut barrier dysfunction in alcoholic liver disease Hepatology 50 2009 638 644
55. A Sajjad, M Mottershead, WK Syn, R Jones, S Smith, CU Nwokolo Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis Aliment Pharmacol Ther 22 2005 291 299
56. A Aderem, RJ Ulevitch Toll-like receptors in the induction of the innate immune response Nature 406 2000 782 787
57. AG Ruiz, F Casafont, J Crespo, A Cayón, M Mayorga, A Estebanez et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of nonalcoholic steatohepatitis Obes Surg 17 2007 1374 1380
58. SQ Yang, HZ Lin, MD Lane, M Clemens, AM Diehl Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis Proc Natl Acad Sci U S A 94 1997 2557 2562
59. K Imajo, K Fujita, M Yoneda, Y Nozaki, Y Ogawa, Y Shinohara et al. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling Cell Metab 16 2012 44 54
60. PD Cani, J Amar, MA Iglesias, M Poggi, C Knauf, D Bastelica et al. Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 2007 1761 1772
61. T Csak, A Velayudham, I Hritz, J Petrasek, I Levin, D Lippai et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice Am J Physiol Gastrointest Liver Physiol 300 2011 G433 G441
62. A Alisi, M Manco, R Devito, F Piemonte, V Nobili Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children J Pediatr Gastroenterol Nutr 50 2010 645 649
63. AL Harte, NF da Silva, SJ Creely, KC McGee, T Billyard, EM Youssef-Elabd et al. Elevated endotoxin levels in non-alcoholic fatty liver disease J Inflamm (Lond) 7 2010 15
64. G Zhang, S Ghosh Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors J Endotoxin Res 6 2000 453 457
65. K Miura, Y Kodama, S Inokuchi, B Schnabl, T Aoyama, H Ohnishi et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice Gastroenterology 139 2010 323 334.e7
66. WP Cawthorn, JK Sethi TNF-alpha and adipocyte biology FEBS Lett 582 2008 117 131
67. J Henao-Mejia, E Elinav, C Jin, L Hao, WZ Mehal, T Strowig et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185
68. DE Vance Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis Curr Opin Lipidol 19 2008 229 234
69. SH Zeisel, JS Wishnok, JK Blusztajn Formation of methylamines from ingested choline and lecithin J Pharmacol Exp Ther 225 1983 320 324
70. ME Dumas, RH Barton, A Toye, O Cloarec, C Blancher, A Roth-well et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice Proc Natl Acad Sci U S A 103 2006 12511 12516
71. AL Buchman, MD Dubin, AA Moukarzel, DJ Jenden, M Roch, KM Rice et al. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation Hepatology 22 1995 1399 1403
72. T Le Roy, M Llopis, P Lepage, A Bruneau, S Rabot, C Bevilacqua et al. Intestinal microbiota determines development of nonalcoholic fatty liver disease in mice Gut 62 2013 1787 1794
73. WC Wu, W Zhao, S Li Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats World J Gastroenterol 14 2008 313 317
74. XS Fu, F Jiang Cisapride decreasing orocecal transit time in patients with nonalcoholic steatohepatitis Hepatobiliary Pancreat Dis Int 5 2006 534 537
75. L Miele, V Valenza, G La Torre, M Montalto, G Cammarota, R Ricci et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease Hepatology 49 2009 1877 1887
76. JM Sabaté, P Jouët, F Harnois, C Mechler, S Msika, M Grossin et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis Obes Surg 18 2008 371 377
77. AA Shanab, P Scully, O Crosbie, M Buckley, L O'Mahony, F Shanahan et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8 Dig Dis Sci 56 2011 1524 1534
78. A Soza, A Riquelme, R González, M Alvarez, RM Pérez-Ayuso, JC Glasinovic et al. Increased orocecal transit time in patients with nonalcoholic fatty liver disease Dig Dis Sci 50 2005 1136 1140
79. AJ Wigg, IC Roberts-Thomson, RB Dymock, PJ McCarthy, RH Grose, AG Cummins The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of nonalcoholic steatohepatitis Gut 48 2001 206 211
80. GR Gibson, JH Cummings, GT Macfarlane, C Allison, I Segal, HH Vorster et al. Alternative pathways for hydrogen disposal during fermentation in the human colon Gut 31 1990 679 683
81. K Triantafyllou, C Chang, M Pimentel Methanogens, methane and gastrointestinal motility J Neurogastroenterol Motil 20 2014 31 40
82. BS Samuel, JI Gordon A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism Proc Natl Acad Sci U S A 103 2006 10011 10016
83. M Pimentel, AG Mayer, S Park, EJ Chow, A Hasan, Y Kong Methane production during lactulose breath test is associated with gastrointestinal disease presentation Dig Dis Sci 48 2003 86 92
84. RJ Basseri, B Basseri, M Pimentel, K Chong, A Youdim, K Low et al. Intestinal methane production in obese individuals is associated with a higher body mass index Gastroenterol Hepatol (N Y) 8 2012 22 28
85. R Mathur, M Amichai, KS Chua, J Mirocha, GM Barlow, M Pimentel Methane and hydrogen positivity on breath test is associated with greater body mass index and body fat J Clin Endocrinol Metab 98 2013 E698 E702
86. R Mathur, G Kim, W Morales, J Sung, E Rooks, V Pokkunuri et al. Intestinal Methanobrevibacter smithii but not total bacteria is related to diet-induced weight gain in rats Obesity (Silver Spring) 21 2013 748 754
87. C Hill, F Guarner, G Reid, GR Gibson, DJ Merenstein, B Pot et al. Expert consensus document The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11 2014 506 514
88. Y Ritze, G Bárdos, A Claus, V Ehrmann, I Bergheim, A Schwiertz et al. Lactobacillus rhamnosus GG protects against nonalcoholic fatty liver disease in mice PLoS One 9 2014 e80169
89. H Okubo, H Sakoda, A Kushiyama, M Fujishiro, Y Nakatsu, T Fukushima et al. Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model Am J Physiol Gastrointest Liver Physiol 305 2013 G911 G918
90. H Endo, M Niioka, N Kobayashi, M Tanaka, T Watanabe Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis PLoS One 8 2013 e63388
91. R Aller, DA De Luis, O Izaola, R Conde, M Gonzalez Sagrado, D Primo et al. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial Eur Rev Med Pharmacol Sci 15 2011 1090 1095
92. P Vajro, C Mandato, MR Licenziati, A Franzese, DF Vitale, S Lenta et al. Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease J Pediatr Gastroenterol Nutr 52 2011 740 743
93. M Malaguarnera, M Vacante, T Antic, M Giordano, G Chisari, R Acquaviva et al. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis Dig Dis Sci 57 2012 545 553
94. VW Wong, GL Won, AM Chim, WC Chu, DK Yeung, KC Li et al. Treatment of nonalcoholic steatohepatitis with probiotics A proof-of-concept study. Ann Hepatol 12 2013 256 262
95. YY Ma, L Li, CH Yu, Z Shen, LH Chen, YM Li Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis World J Gastroenterol 19 2013 6911 6918
96. BJ Vesper, A Jawdi, KW Altman, GK Haines 3rd, L Tao, JA Rados-evich The effect of proton pump inhibitors on the human microbiota Curr Drug Metab 10 2009 84 89
97. EA Lin, GM Barlow, R Mathur The microbiome in nonalcoholic fatty liver disease: associations and implications Ann Gastroenterol 27 2014 181 183